Abstracts

  • Abstract submission will open by the end of 2018. The deadline for abstract submission is set on 12 April, 2019.


 General guidelines

 Abstracts should contain the following four components:

  • Background: a concise statement of the issue under investigation or a hypothesis;
  • Material & Methods: the experimental methods used (including the statistical analyses employed);
  • Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
  • Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially.

Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.

Abstract submission

Authors can submit their abstracts electronically until the given deadline by using “ABSTRACT SUBMISSION” button on the right. This will direct you to the appropriate webpage. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission

For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics for abstract submission:

  • Basic Science of Hepatitis/HIV
  • Clinical Management of Hepatitis/HIV
  • Epidemiology of Hepatitis/HIV
  • Resistance to Hepatitis/HIV
  • Vaccine Development for HIV
  • Eradication & Cure of Hepatitis

Notification of abstract acceptance and presentation format

Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed to the submitting author.

It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract's status. Please notify the Conference Secretariat if you have not received notification one month after the closing date for abstract submission.

If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication

Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.